Home Amgen, Allergan Biosimilar Avastin Hits In Trial
 

Keywords :   


Amgen, Allergan Biosimilar Avastin Hits In Trial

2015-09-24 17:07:51| Biotech - Topix.net

Amgen and Allergan, which started their collaboration back in 2011 when Allergan was a generic drug maker called Watson Pharmaceuticals, released few details but said the drug ABP 215 had shown clinical equivalence to Avastin as measured by tumor shrinkage, duration of response and progression-free survival. Launched in 2004, Avastin is drawing $7 billion for Roche as a treatment for a variety of different cancers, about 20% to 25% of it from lung cancer.

Tags: trial hits amgen allergan

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11S
24.11
24.115
24.11SR
24.11 RC24.4.5
24.11115+128717dz
24.11lavaSUKALA 3
24.11508A
More »